Intervention Review

Beta-blockers for hypertension

  1. Charles Shey Wiysonge1,*,
  2. Hazel A Bradley2,
  3. Jimmy Volmink3,4,
  4. Bongani M Mayosi5,
  5. Anthony Mbewu6,
  6. Lionel H Opie7

Editorial Group: Cochrane Hypertension Group

Published Online: 14 NOV 2012

Assessed as up-to-date: 27 FEB 2012

DOI: 10.1002/14651858.CD002003.pub4


How to Cite

Wiysonge CS, Bradley HA, Volmink J, Mayosi BM, Mbewu A, Opie LH. Beta-blockers for hypertension. Cochrane Database of Systematic Reviews 2012, Issue 11. Art. No.: CD002003. DOI: 10.1002/14651858.CD002003.pub4.

Author Information

  1. 1

    University of Cape Town, Division of Medical Microbiology & Institute of Infectious Disease and Molecular Medicine, Observatory, South Africa

  2. 2

    University of the Western Cape, School of Public Health, Cape Town, South Africa

  3. 3

    Stellenbosch University, Faculty of Medicine and Health Sciences, Tygerberg, South Africa

  4. 4

    South African Medical Research Council, South African Cochrane Centre, Tygerberg, Western Cape, South Africa

  5. 5

    J Floor, Old Groote Schuur Hospital, Department of Medicine, Cape Town, South Africa

  6. 6

    University of Cape Town, Department of Medicine, Faculty of Health Sciences, Cape Town, South Africa

  7. 7

    Medical School, Hatter Cardiovascular Research Institute, Cape Town, South Africa

*Charles Shey Wiysonge, Division of Medical Microbiology & Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Anzio Road, Observatory, 7925, South Africa. charles.wiysonge@uct.ac.za. wiysonge@yahoo.com.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 14 NOV 2012

SEARCH

No citations currently available for this article.